Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)
Pharma-Bio Serv (PBSV) reported Short term Debt of $1.3 million for Q2 2021, up 100.0% year-over-year from $643900.0 in Q2 2020, and little changed on a QoQ basis from $1.3 million in Q1 2021.
Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv's Short term Debt history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2021.
- Short term Debt for Q2 2021 came in at $1.3 million, up 100.0% year-over-year; the trailing twelve-month figure through Apr 2021 was $1.3 million (up 100.0% YoY), and the FY2020 annual result was $1.3 million, changed N/A from the prior year.
- Short term Debt came in at $1.3 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.3 million in Q4 2020 to a low of $643900.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 1.29 Mn |
| Jan 31, 2021 | 1.29 Mn |
| Oct 31, 2020 | 1.29 Mn |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 643,900.00 |